Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U0VU
|
||||
Former ID |
DNC004927
|
||||
Drug Name |
SILODOSIN
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H32F3N3O4
|
||||
InChI |
InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1
|
||||
InChIKey |
PNCPYILNMDWPEY-QGZVFWFLSA-N
|
||||
CAS Number |
CAS 160970-54-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7849027, 7979683, 11056891, 12014894, 14810706, 14835413, 39341745, 57359519, 80176928, 92098546, 99299508, 103194366, 104046714, 109693099, 114157936, 126623000, 126665711, 128939931, 131300819, 134339064, 134340151, 134342132, 135252710, 135368407, 135650458, 135916576, 137248544, 142093997, 152258092, 152344280, 160646931, 162011672, 162172235, 162223757, 163884568, 164765008, 164777753, 172085148, 174527805, 175266679, 175427058, 175612190, 179150028, 184816547, 187071911, 198991703, 202821102, 211536181, 223392962, 223484371
|
||||
SuperDrug ATC ID |
G04CA04
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1A adrenergic receptor | Target Info | Inhibitor | [527393] | |
PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
References | |||||
Ref 468101 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 493). | ||||
Ref 529941 | 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6. | ||||
Ref 530665 | Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clin Ther. 2009 Nov;31(11):2489-502. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.